CG
XPH icon

Cutler Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Cutler Group’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-330
Closed -$13K – 4417
2023
Q2 		$13K Sell
330
-3
-0.9% -$124 ﹤0.01% 2119
2023
Q1 		$13K Sell
333
-897
-73% -$37.7K ﹤0.01% 2179
2022
Q4 		$50K Buy
1,230
+370
+43% +$15.4K ﹤0.01% 1576
2022
Q3 		$34K Sell
860
-140
-14% -$5.99K ﹤0.01% 2203
2022
Q2 		$42K Buy
1,000
+480
+92% +$20.1K ﹤0.01% 2079
2022
Q1 		$23K Buy
520
+100
+24% +$4.39K ﹤0.01% 2946
2021
Q4 		$19K Sell
420
-80
-16% -$3.79K ﹤0.01% 3184
2021
Q3 		$23K Sell
500
-200
-29% -$9.94K ﹤0.01% 3246
2021
Q2 		$36K Buy
700
+100
+17% +$5.02K ﹤0.01% 2781
2021
Q1 		$30K Hold
600
– – ﹤0.01% 2852
2020
Q4 		$31K Hold
600
– – ﹤0.01% 2348
2020
Q3 		$26K Sell
600
-200
-25% -$8.76K ﹤0.01% 2270
2020
Q2 		$34K Buy
800
+700
+700% +$28.9K ﹤0.01% 2030
2020
Q1 		$3K Sell
100
-100
-50% -$4.26K ﹤0.01% 3376
2019
Q4 		$9K Hold
200
– – ﹤0.01% 2717
2019
Q3 		$7K Buy
+200
New +$7.43K ﹤0.01% 2863
2019
Q1 		– Sell
-100
Closed -$3K – 4869
2018
Q4 		$3K Sell
100
-100
-50% -$4.27K ﹤0.01% 3254
2018
Q3 		$9K Buy
+200
New +$9.47K ﹤0.01% 2743
2018
Q2 		– Sell
-100
Closed -$4.2K – 5010
2018
Q1 		$4K Sell
100
-700
-88% -$30.5K ﹤0.01% 3461
2017
Q4 		$34K Buy
800
+500
+167% +$21.3K ﹤0.01% 2162
2017
Q3 		$12K Buy
+300
New +$12.7K ﹤0.01% 3663
2017
Q2 		– Sell
-521
Closed -$21K – 7204
2017
Q1 		$21K Sell
521
-1,479
-74% -$60.3K ﹤0.01% 3290
2016
Q4 		$78K Sell
2,000
-4,100
-67% -$167K ﹤0.01% 2132
2016
Q3 		$269K Buy
6,100
+2,300
+61% +$104K 0.01% 992
2016
Q2 		$158K Buy
3,800
+2,300
+153% +$97.4K 0.01% 1306
2016
Q1 		$60K Buy
+1,500
New +$63.5K ﹤0.01% 2136

Other funds holding XPH

CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Cutler Group's XPH Position: Q3 2023 in Review

Cutler Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2023, closing a stake of 330 shares — an estimated $13K sold.

Cutler Group first reported a position in XPH in Q1 2016 and held it in 26 quarters. The position peaked at $269K in Q3 2016. 65 funds tracked by Wall St. Rank hold XPH as of Q3 2023.

  • Cutler Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 330 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2023, an estimated $13K.
  • Cutler Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2016 and held it in 26 quarters.
  • Cutler Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $269K in Q3 2016.
  • 65 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.